European Journal of Contraception and Reproductive Health Care

Papers
(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!65
Retraction45
RETRACTED ARTICLE: Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial36
Statement of Retraction: Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices22
Statement of Retraction: Benefits of vaginal misoprostol prior to IUD insertion in women with previous caesarean delivery: a randomised controlled trial20
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]19
The use and access to contraception in Sweden during the COVID-19 pandemic period17
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis15
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review14
Fertility awareness and parenthood intentions among medical students in three European countries14
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain13
Sexual behaviour, contraceptive use, and family planning intentions: 30 years of repeated cross-sectional surveys12
Clinical improvement after Essure® devices removal: a systematic review11
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction10
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study10
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users9
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain9
Statement of Retraction: “Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS”9
The cost burden of adolescent and young adult pregnancy: real-world evidence from the Brazilian public health care system8
Contraception utilization in women with pregestational diabetes8
Women’s autonomy and modern contraceptive use in Ghana: a secondary analysis of data from the 2014 Ghana Demographic and Health Survey8
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey8
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion8
mHealth and its application in menstrual related issues: a systematic review8
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France7
Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning7
Minimally invasive transurethral holmium laser surgery for the management of an IUD with bladder migration7
How often is oral contraception used for contraception? The need of benefit’s formalisation7
The March 2021 Italian constitutional court ruling on surrogacy: a prelude to common European legislation for the sake of reproductive health?7
Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system6
Pooled incidence of continuation and pregnancy rates of four contraceptive methods in young women: a meta-analysis6
The use of long-acting and permanent contraceptive methods (LAPMs) among women who have completed childbearing in Indonesia: does informed choice matter?6
Exploring male perceptions regarding the need to engage in preconception care – a mixed-method study amongst Dutch (prospective) fathers6
Pain relief during intrauterine device placement in nulligravid women with both oral ketorolac and an analgesic: a double-blinded randomised trial5
Impact of Covid-lockdown on abortion management at a family planning in Brussels5
Correction5
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives5
Practical training of health care providers in insertion of contraceptive implants: findings from two Brazilian centres5
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic5
Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena® satisfaction study5
A pioneer of hormonal contraception: Joseph W. Goldzieher5
Overnight pain and opioid use after osmotic cervical dilator placement for second trimester dilation and evacuation4
Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil4
Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations4
Health benefits of combined oral contraceptives – a narrative review4
Exploring technology-based interventions to improve oral contraceptive pill adherence: a cross-sectional survey4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition4
Impact of a post-partum family planning intervention on contraception and fertility in Tanzania: two-year follow-up of a cluster-randomised controlled trial4
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women4
The global pandemic and changes in women’s reproductive health: an observational study4
The significant influence of history of induced abortion on the utilisation of long-acting reversible contraceptive methods in the immediate post abortion period, Northern Ethiopia4
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort4
Migration and newborn screening: time to build on the European Asylum, Integration and Migration Fund?4
The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgen: Correspondence4
The demand for family planning to limit childbearing satisfied with female permanent contraception in Sub-Saharan Africa: a meta-analysis of demographic and health surveys3
Statement of Retraction [Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial]3
Tips and tricks for the management of contraceptive etonogestrel implant in clinical practice: an Expert Opinion3
The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgens: a pilot study3
Evaluation of the impact of humor used in contraception education on the attitudes of university students towards contraceptive methods3
Statement of Retraction [Lidocaine gel vs lidocaine spray in reducing pain during insertion of the intrauterine contraceptive device]3
The prolonged-release oral formulations: a new era in hormonal contraception technology?3
Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy3
Preabortion ultrasound – a patient perspective3
RETRACTED ARTICLE: Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices3
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial throm3
The personal experience of female obstetricians and gynaecologists with contraceptive use influences the guidance and prescription of contraceptive methods: a web-survey3
Critical commentary on ‘Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature’3
0.14040803909302